Equibles does not estimate personal net worth.
Get an email with a short summary when Allogene Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ALLO alertsChristine Cassiano has spoken on 2 earnings calls across 1 company, most recently for Allogene Therapeutics, Inc. on August 12, 2026. Allogene Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Allogene Therapeutics, Inc. includes Zachary Roberts, M.D., Ph.D. (CEO and Board Member), Geoffrey Parker (CFO), Tim Moore (CTO) and 5 others.
“After the market closed, Allogene issued a press release that provided a business update and financial results for the second quarter of 2026. This press release and today's webcast are available on our website.”
“After the market closed, Allogene issued a press release that provided a business update and financial results for the first quarter of 2026. This press release and today's webcast are available on our website.”
Source not stated
Biotechnology · Healthcare
